The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Klein Norman Paul Ii since 2007.
The trader's CIK number is 1384652.
At the time of the last reporting, Klein Norman Paul Ii was the Corporate Operations of Cellular Biomedicine Group, Inc.. (stock ticker symbol CBMG).
Also see all insider trading activities at Cellular Biomedicine Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | EBIG | 0 | $0 | 1,407,885 | $112,630 | 0 | $0 |
| 2010 | EBIG | 0 | $0 | 537,115 | $34,912 | 0 | $0 |
| 2009 | EBIG | 1,650,420 | $27,781 | 923,712 | $16,626 | 0 | $0 |
| 2008 | EBIG | 4,205,698 | $207,370 | 720,900 | $32,463 | 0 | $0 |
| 2007 | EBIG | 3,206,896 | $336,348 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-02-11 | EBIG | Sale | 1,407,885 | .08 | 112,630 |
| 2010-10-05 | EBIG | Sale | 537,115 | .07 | 34,912 |
| 2009-08-21 | EBIG | Sale | 923,712 | .02 | 16,626 |
| 2009-05-22 | EBIG | Buy | 641,720 | .01 | 9,625 |
| 2009-02-25 | EBIG | Buy | 1,008,700 | .02 | 18,156 |
| 2008-11-14 | EBIG | Buy | 1,174,284 | .03 | 35,228 |
| 2008-10-18 | EBIG | Buy | 723,114 | .03 | 21,693 |
| 2008-09-18 | EBIG | Buy | 503,300 | .03 | 15,099 |
| 2008-07-09 | EBIG | Sale | 600,000 | .04 | 24,000 |
| 2008-05-23 | EBIG | Buy | 5,000 | .07 | 350 |
| 2008-05-23 | EBIG | Sale | 120,900 | .07 | 8,463 |
| 2008-02-28 | EBIG | Buy | 1,800,000 | .07 | 135,000 |
| 2007-11-05 | EBIG | Buy | 2,233,563 | .07 | 156,349 |
| 2007-11-06 | EBIG | Buy | 100,000 | .10 | 10,000 |
| 2007-08-30 | EBIG | Buy | 400,000 | .07 | 28,000 |
| 2006-12-28 | UNKNOWN | Buy | 473,333 | .30 | 141,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klein Norman Paul Ii (Corporate Operations of Cellular Biomedicine Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.